Market capitalization | $69.90m |
Enterprise Value | $70.31m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
P/B ratio (TTM) P/B ratio | 3.56 |
Revenue (TTM) Revenue | $0.00 |
EBIT (operating result TTM) EBIT | $-24.43m |
Free Cash Flow (TTM) Free Cash Flow | $-19.46m |
Cash position | $19.65m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
3 Analysts have issued a Vivani Medical forecast:
3 Analysts have issued a Vivani Medical forecast:
Sep '24 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | -0.41 -0.41 |
11%
11%
|
|
EBITDA | -24 -24 |
15%
15%
|
EBIT (Operating Income) EBIT | -24 -24 |
14%
14%
|
Net Profit | -23 -23 |
13%
13%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Vivani Medical, Inc. develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. The company was founded on May 22,2003 and is headquartered in Alameda, CA.
Head office | United States |
CEO | Adam Mendelsohn |
Employees | 44 |
Founded | 2003 |
Website | www.vivani.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.